Depression and Parkinson's Disease are at the center of our research efforts, as these conditions affect millions globally and require new, innovative treatment methods.

Through our work with the Re5 technology and in collaboration with Danish researchers and treating physicians, we strive to open up new treatment pathways that can offer effective relief without the side effects traditionally associated with pharmacological products.

There is also research with the Re5 technology in post-concussion syndrome (PCS), and multiple chemical sensitivity (MCS), where there is an urgent need for more awareness and understanding.

If you are a professional, you are welcome to contact us with specific ideas for new research.